The elevated IL-38 levels observed in RA patients—paralleling the compensatory IL-37 response discussed earlier—may indicate an endogenous anti-inflammatory mechanism that becomes inadequate in severe or treatment-resistant cases. This evidence concerns the gene IL37 and rheumatoid arthritis.